Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:



Albania (3)
Algeria (1)
Argentina (2)
Australia (26)
Austria (107)
Bangladesh (2)
Belgium (150)
Benin (1)
Bosnia and Herzegovina (2)
Brazil (13)
Bulgaria (8)
Burkina Faso (1)
Cambodia (1)
Canada (16)
Chile (1)
China (7)
Colombia (4)
Costa Rica (2)
Croatia (12)
Cuba (2)
Cyprus (3)
Czech Republic (38)
Denmark (102)
Egypt (1)
El Salvador (1)
Estonia (15)
Finland (75)
Former Yugoslav Republic of Macedonia (1)
France (255)
French Polynesia (1)
Gabon (2)
Germany (356)
Ghana (4)
Greece (46)
Guatemala (1)
Haiti (1)
Hong Kong (1)
Hungary (35)
Iceland (15)
India (8)
Indonesia (3)
Iran (1)
Ireland (56)
Israel (46)
Italy (215)
Japan (3)
Jordan (1)
Kazakhstan (1)
Kenya (3)
Latvia (7)
Lebanon (1)
Lithuania (9)
Luxembourg (13)
Malaysia (2)
Malta (1)
Mauritius (1)
Mexico (5)
Moldova (1)
Morocco (2)
Mozambique (1)
Netherlands (263)
New Zealand (3)
Nigeria (2)
Norway (29)
Oman (1)
Pakistan (2)
Palestine (1)
Papua New Guinea (1)
Poland (37)
Portugal (27)
Romania (14)
Russia (6)
Serbia (4)
Singapore (3)
Slovakia (7)
Slovenia (14)
South Africa (7)
South Korea (1)
Spain (171)
Sri Lanka (2)
Sudan (1)
Sweden (145)
Switzerland (145)
Syria (1)
Taiwan (1)
Tanzania (5)
Thailand (4)
Tunisia (3)
Turkey (10)
Ukraine (1)
United Kingdom (364)
United States (52)
Uzbekistan (1)
Venezuela (1)
Vietnam (3)


English (413)

Advanced search

Results 1 - 10 of 413
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Disarming the intravascular innate immune response to improve treatment modalities for chronic kidney disease
ID: 602699
Start date: 2013-12-01, End date: 2017-11-30
Chronic kidney disease is world wide a major cause of end-stage renal disease (ESRD). 800.000 patients in Europe and in the US, respectively, require long-term treatment initially with peritoneal dialysis, followed by hemodialysis and kidney transplantation. Each ESRD patient...
Programme: FP7-HEALTH
Record Number: 110780
Last updated on: 2017-04-24
Optimized Diagnostics for Improved Treatment Stratification in Invasive Fungal Diseases
ID: 602125
Start date: 2014-02-01, End date: 2019-01-31
Invasive fungal disease (IFD) is a leading cause of morbidity and mortality in the growing number of immunocompromised individuals, including particularly cancer patients, and bone-marrow or organ transplant recipients. The majority of IFD events are still caused by Candida a...
Programme: FP7-HEALTH
Record Number: 110939
Last updated on: 2017-04-24
Evaluation of phage therapy for the treatment of Escherichia coli and Pseudomonas aeruginosa burn wound infections (Phase I-II clinical trial)
ID: 601857
Start date: 2013-06-01, End date: 2017-02-28
Sepsis is the major problem of large burn patients and a predominant cause of death. The burn wound pathology, combined to a global intensive use of antibiotics (ATB), put patients at high risk of suffering from multidrug resistant (MDR) infections, notably carried out by the...
Programme: FP7-HEALTH
Record Number: 108695
Last updated on: 2017-04-24
THE MILESTONE PROJECT: Managing the Link and Strengthening Transition from Child to Adult Mental Health Care
ID: 602442
Start date: 2014-02-01, End date: 2019-01-31
Transition to adulthood is the period of onset of most of the serious mental disorders that disable or kill in adult life. Current service configuration of distinct Child and Adolescent Mental Health (CAMHS) and Adult Mental Health (AMHS) Services is considered the weakest li...
Programme: FP7-HEALTH
Record Number: 110200
Last updated on: 2017-04-10
European-study on Quantifying Utility of Investment in Protection from Tobacco
ID: 602270
Start date: 2013-10-01, End date: 2016-09-30
Tobacco smoking costs the EU an estimated 98 to 130 billion Euros each year – just above 1% of the EU Gross Domestic Product in 2000. A large, robust and consistent evidence base indicates that coordinated, high impact and comprehensive approaches are the most effective way t...
Programme: FP7-HEALTH
Record Number: 110172
Last updated on: 2017-04-10
Development of an innovative paediatric formulation of an antiepileptic agent for the treatment of absence epilepsy in children
ID: 282559
Start date: 2011-10-01, End date: 2017-03-31
The KIEKIDS project is dedicated to the development of an innovative paediatric formulation of an antiepileptic agent for a safe alternative treatment of absence epilepsy in children. Development of such an age-appropriate formulation is regarded by The European Medicines Age...
Programme: FP7-HEALTH
Record Number: 100437
Last updated on: 2017-04-10
A BLUEPRINT of Haematopoietic Epigenomes
ID: 282510
Start date: 2011-10-01, End date: 2016-09-30
In response to the call for a high impact initiative on the human epigenome, the BLUEPRINT Consortium has been formed with the aim of generating at least 100 reference epigenomes and studying them to advance and exploit knowledge of the underlying biological processes and mec...
Programme: FP7-HEALTH
Record Number: 99677
Last updated on: 2017-04-10
Supporting sustainable participation of industry, in particular high-technology, research-intensive SMEs in EU-funded research in the Health Sector
ID: 602428
Start date: 2013-11-01, End date: 2017-10-31
Fit for Health 2.0 aims to promote and enhance a sustainable participation of European industry in the Health-related sector of Horizon 2020 (H2020). Focusing on research-intensive, high technology SMEs the project offers targeted support measures, covering the entire innovat...
Programme: FP7-HEALTH
Record Number: 109464
Last updated on: 2017-04-03
Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancers
ID: 602200
Start date: 2013-09-01, End date: 2017-08-31
Studies have demonstrated the importance of CD73 in the spread of cancer. Overexpressed in numerous cancer types, this enzyme leads to the production of high amounts of extracellular Adenosine, creating an immunosuppressive microenvironment, and contributing to tumor prolifer...
Programme: FP7-HEALTH
Record Number: 110188
Last updated on: 2017-04-03
Developing predictors of the health benefits of exercise for individuals
ID: 277936
Start date: 2011-12-01, End date: 2016-05-31
Physical activity is a powerful lifestyle factor that on average reduces risk for development of diabetes and cardiovascular disease. Nevertheless, we have demonstrated that following supervised endurance exercise training, 20% of subjects show no change in fitness and 30% de...
Programme: FP7-HEALTH
Record Number: 102238
Last updated on: 2017-04-03
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-04-27
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top